Filterlex Medical
Filterlex created the CAPTIS® intra-aortic EPD to deflect, capture, and remove embolic particles during TAVI. This new EPD offers full-body protection by trapping and eliminating embolic debris.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
* | N/A | $6.0m | Series A |
| Total Funding | 000k | ||
Related Content
Developer of an embolic protection device designed to help patients with complications during catheter-based structural heart procedures. The company's device uses next-generation technology to meet the need of current product limitations and weaknesses and is securely positioned in the aorta to provide full-body embolic protection by deflecting, capturing, and removing embolic particles, enabling physicians to reduce the risk of stroke and other complications during catheter-based structural heart procedures.
Keywords: Pharmaceuticals and Biotechnology, Cardiovascular Tools, Embolic Protection Device, Embolic Protection System, Embolic Protection Technology, Stroke Cure, Surgical Technology.